Integrative computational-experimental discovery of α-hederin as a multi-mechanistic, low-toxicity antifungal agent targeting Candida albicans CYP51
Lists
Only you see this
Abstract
This study advances antifungal drug discovery by validating CYP51 as a high-value target for structure-guided screening, identifying α-hederin as a low-toxicity, multi-mechanistic antifungal agent and establishing a computational-experimental framework for rapid antifungal development.
BibTeX
@article{wang2025integrative,
author = {Xuan Wang and Yuchun Zhang and Gansukh Sunderiya and Zhenqi Xin and Yulan Ji and Saixue Yang and Di Han and Xianqing Chen and Dongyan Shao and Junling Shi and Chunmei Jiang},
title = {{Integrative computational-experimental discovery of α-hederin as a multi-mechanistic, low-toxicity antifungal agent targeting Candida albicans CYP51}},
journal = {Journal of Advanced Research},
year = {2025},
doi = {10.1016/j.jare.2025.11.063},
}Loading related content...